Prof. Feng Wang 王峰
Chief Physician, Professor
Department of Head and Neck Oncology, West China Hospital, Sichuan University, Chengdu
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiation therapy, chemotherapy, and comprehensive treatment for head and neck, thoracic, and abdominal tumors. Three-dimensional conformal radiation therapy and intensity-modulated radiation therapy for common malignant tumors.
Dr. Wang is a Chief Physician, Professor, and holds a medical doctorate. Since 1990, Dr. Wang has worked in clinical radiation therapy and research. Training includes a 1996 fellowship at the Cancer Hospital of the Chinese Academy of Medical Sciences and a 2001 visiting researcher role at Tohoku University, Japan. Dr. Wang earned a PhD from Tohoku University in 2006. Research focuses on precancerous lesions and DNA damage and repair.
Professional roles
- Member, Japanese Society for Therapeutic Radiology and Oncology
Name order: in Chinese the family name comes first (Wang Feng). Papers usually list the name as Feng Wang or Wang F.
Selected publications
118 papers on PubMed matched by name and affiliation; 24 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Med (Lausanne), 2026 (senior author): The therapeutic revolution in thyroid eye disease: from orbital radiotherapy to teprotumumab and AI. PubMed 41728592
- Int J Surg, 2026 (senior author): Associations of genetically proxied inhibition of HMGCR and PCSK9 with gastrointestinal cancer: a drug target Mendelian randomization study. PubMed 41731883
- Expert Rev Neurother, 2025 (senior author): Integration of artificial intelligence in the clinical management of medulloblastoma: from precision diagnosis to dynamic prognosis. PubMed 41147843
- Genes Dis, 2025 (senior author): CCDC86-BHLHE40-ATF3 axis promotes aerobic glycolysis and tumor development in glioma. PubMed 40837407
- Cancer Cell, 2025 (first author): Neoadjuvant treatment of IBI310 plus sintilimab in locally advanced MSI-H/dMMR colon cancer: A randomized phase 1b study. PubMed 41043438
- Int J Biol Macromol, 2025 (senior author): Circular RNAs in glioma progression: Fundamental mechanisms and therapeutic potential: A review. PubMed 40388873
- Biomark Res, 2025 (senior author): Epigenetic regulation of histone modifications in glioblastoma: recent advances and therapeutic insights. PubMed 40450300
- Aging Clin Exp Res, 2025 (senior author): Frailty, high-sensitivity C-reactive protein and cardiovascular disease: a nationwide prospective cohort study. PubMed 40021565
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion